Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

PMEA 2019: Recognising excellence in improving patient outcomes

The 19th annual PMEA programme saw its highest number of entries yet

- PMLiVE

Merck’s Keytruda significantly extends life in some prostate cancer patients

Pivotal study identifies group of 'super responders'

- PMLiVE

Incyte claims FDA priority review for bile duct cancer drug

Significant need for new therapies in hard-to-treat cancer type

- PMLiVE

Labour clashes with government on ‘NHS for sale’ claims

Government maintains NHS will remain off the table in negotiations

- PMLiVE

Pfizer’s Ibrance scores second-line breast cancer approval via NICE’s Cancer Drugs Fund

Around 3,200 women in England could be eligible for treatment

- PMLiVE

Lucid Group announces the appointment of a new Legal and Compliance manager

Lucid Group demonstrates continual investment in its infrastructure by appointing Sebastian Goodwin as its new Legal and Compliance manager.Sebastian studied politics and trained to be a lawyer before moving into...

Lucid Group Communications Limited

- PMLiVE

Lucid Group Experience the Magic of Mindfulness, Meditation and Massage

This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...

Lucid Group Communications Limited

- PMLiVE

Merck’s Keytruda picks up third approval for NSCLC in China

New indication as a first-line treatment in combination with chemotherapy

- PMLiVE

AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER

Updated draft evidence report maintains the benefit is small with higher price tag

- PMLiVE

New faces at Lucid Group and ZPB Associates

Latest movers in healthcare comms

- PMLiVE

ChemoCentryx surges on phase 3 vasculitis study

Shares in the US biotech rose 227% after announcing trial results

- PMLiVE

Q&A: Vicky Bramham

PME interviews OPEN Health Patient & Brand Communications' managing director, PR

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links